Low-temperature curing catalysts using tio₂ nanotubes for advanced coatings
Innovative TiO₂ nanotube-based catalysts enhance curing kinetics of epoxy and melamine coatings, reducing curing temperatures and time while maintaining stability. This energy-efficient solution meets industrial demands for environmentally compliant coatings.
Overview
The low-temperature curing catalysts utilizing TiO₂ nanotubes represent a breakthrough in advanced coating technologies. These catalysts are designed to enhance the curing kinetics of epoxy and melamine-based coatings, offering a significant reduction in curing temperatures by at least 20°C and decreasing dry-through time by 50%. This innovation not only maintains the pot-life and shelf-life stability of coatings but also adheres to energy-efficient and environmentally compliant standards, making it ideal for various industrial applications.
Technical specifications
These catalysts leverage the unique properties of TiO₂ nanotubes, which include high surface area, tunable porosity, and exceptional chemical stability. By incorporating surface modifications such as organic functionalization or doping with elements like Ni and Ce, these catalysts effectively lower activation energy requirements, enhancing catalytic activity. The technology involves the synthesis of TiO₂ nanotubes via anodization, optimized for high aspect ratios, followed by surface doping and functionalization to maximize efficiency. The catalysts are tested in epoxy-amine and melamine systems, utilizing techniques such as DSC and TGA to measure curing temperature reductions and reaction rates.
Technology readiness level
Currently, this technology is at TRL 3, indicating that it has been validated in a laboratory environment. Future steps include scaling up for industrial applications and conducting comprehensive evaluations of toxicity, environmental impact, and regulatory compliance.
About University of Minnesota
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.
Inquire about this partnering listing
Industry applications
delivered to your inbox.